Andrographolide and analogues as inhibitors of TNFalpha and IL1betaexpression

Details for Australian Patent Application No. 2005221711 (hide)

Owner Hutchison MediPharma Ltd.

Inventors Wang, Tao; Zhang, Weihan; Hong, Jianrong; Cai, Yu; Yan, Xiaoqiang; Duan, Jeff; Ma, Zhiming; Pan, Ke

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005221711

PCT Pub. Number WO2005/087223

Priority 60/552,329 11.03.04 US

Filing date 11 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/087223 Priority application(s): WO2005/087223

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221712-Identification of self and non-self antigens implicated in autoimmune diseases

2005221710-Pharmaceutical compositions comprising interferon-tau